Compare RKLB & HLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RKLB | HLN |
|---|---|---|
| Founded | 2006 | 2022 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Aerospace | Package Goods/Cosmetics |
| Sector | Industrials | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 37.7B | 43.7B |
| IPO Year | N/A | N/A |
| Metric | RKLB | HLN |
|---|---|---|
| Price | $90.71 | $9.77 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 14 | 1 |
| Target Price | ★ $51.42 | N/A |
| AVG Volume (30 Days) | ★ 29.0M | 8.4M |
| Earning Date | 02-26-2026 | 02-26-2026 |
| Dividend Yield | N/A | ★ 1.82% |
| EPS Growth | N/A | ★ 41.64 |
| EPS | N/A | ★ 0.23 |
| Revenue | $554,535,000.00 | ★ $15,096,588,575.00 |
| Revenue This Year | $40.29 | $1.51 |
| Revenue Next Year | $46.77 | $4.67 |
| P/E Ratio | ★ N/A | $43.50 |
| Revenue Growth | ★ 52.42 | N/A |
| 52 Week Low | $14.71 | $8.71 |
| 52 Week High | $92.19 | $11.42 |
| Indicator | RKLB | HLN |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 45.96 |
| Support Level | N/A | $9.72 |
| Resistance Level | N/A | $10.03 |
| Average True Range (ATR) | 0.00 | 0.13 |
| MACD | 0.00 | -0.05 |
| Stochastic Oscillator | 0.00 | 12.50 |
Rocket Lab Corp is engaged in space, building rockets, and spacecraft. It provides end-to-end mission services that provide frequent and reliable access to space for civil, defense, and commercial markets. It designs and manufactures the Electron and Neutron launch vehicles and Photon satellite platform. Rocket Lab's Electron launch vehicle has delivered multiple satellites to orbit for private and public sector organizations, enabling operations in national security, scientific research, space debris mitigation, Earth observation, climate monitoring, and communications. The business operates in two segments Launch Services and Space Systems. Geographically it serves Japan, Germany, and rest of the world and earns key revenue from the United States.
Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.